Myriad Genetics | MYGN - Ebitda

Prix De L'Action
4.58
Variation Quotidienne
0.23 5.29%
Mensuellement
-0.22%
Annuel
-43.32%
Q2 Prévisions
4.23




Ebitda Changement Date
Agilent USD 540M 74M 2025-09
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Bio-Rad Laboratories USD -374.6M 841.8M 2025-09
Bruker USD 211.6M 207.4M 2025-12
Danaher USD 2.13B 252M 2025-12
Hologic USD 330.4M 16.6M 2025-12
Illumina USD 332M 12M 2025-09
J&J USD 9.52B 389M 2025-09
Mettler Toledo International USD 322.64M 26.75M 2025-09
Myriad Genetics USD 14.3M 4M 2025-12
OraSure Technologies USD -17.7M 4.06M 2025-12
Pacific Biosciences Of California USD -35.4M 5.78M 2025-09
Quest Diagnostics USD 537M 24M 2025-12
Quidel USD 153.3M 23.8M 2025-12
Repligen USD 39.54M 3.61M 2025-12
Revvity USD 248.91M 48.52M 2025-12
Standard Biotools USD -15.81M 734K 2025-12
Thermo Fisher Scientific USD 3.17B 335M 2025-12
Veracyte USD 42.31M 2.58M 2025-12
Waters USD 380.97M 85.83M 2025-12